Background: Recent studies conducted in arthritis, asthma, and inflammatory bowel disease suggest that chitinases are important in inflammatory processes and tissue remodeling.
Objective: To investigate the role of chitinases in multiple sclerosis (MS) and neuromyelitis optica (NMO).
Methods: Levels of chitotriosidase, acid mammalian chitinase (AMCase), and chitinase 3-like-1 (CHI3L1) were measured using ELISA, in cerebrospinal fluid (CSF) and in serum from 24 patients with relapsing remitting (RR) MS, 24 patients with secondary progressive (SP) MS, 12 patients with NMO, 24 patients with other inflammatory neurological diseases (OIND), and 24 healthy controls (HCs). The number of anti-MOG cytokine-secreting cells was studied using ELISPOT. Eotaxins, MCP-1, RANTES, and IL-8 were assessed using ELISA. Cell transmigration was determined using an in vitro blood–brain barrier (BBB) model, in the presence and absence of chitinases.
Results: CSF chitinase levels were significantly increased in patients with RRMS and NMO compared with HCs and patients with SPMS and OIND. In contrast, no significant differences were detected in serum chitinase levels between groups. Chitinase CSF levels showed correlation with anti-MOG IL-13-producing cells, and eotaxin levels. In vitro experiments showed macrophage chitinase secretion was significantly increased by IL-13, but not by IL-5, IL-6, IL-12, or IFN-γ. Moreover, chitinases enhanced IL-8, RANTES, MCP-1, and eotaxin production, increasing migratory capacity in eosinophils, T cells, and macrophages across an in vitro BBB model.
Conclusions: Chitinases increased in the CSF from patients with NMO in response to IL-13. These enhanced levels could contribute to central nervous system inflammation by increasing immune cell migration across the BBB.
NairMGGuildKJArtisD. Novel effector molecules in type 2 inflammation: lessons drawn from helminth infection and allergy. J Immunol2006; 177: 1393–1399.
2.
KawadaMHachiyaYMizoguchiE. Role of the mammalian chitinases in inflammatory conditions. Keio J Med2007; 56: 21–27.
3.
JinHMCopelandNGGilbertDJJenkinsNAKirkpatrickRBRosenbergM. Genetic characterization of a cluster of highly homologous genes. Genomics1998; 276: 2198–2202.
4.
ZhuZZhengTHomerRJKimYKChenNYCohnL. Acid mammalian chitinase in asthmatic Th2 inflammation and IL-13 pathway activation. Science2004; 304: 1678–1682.
5.
MizoguchiE. Chitinase 3-like-1 exacerbates intestinal inflammation by enhancing bacterial adhesion and invasion in colonic epithelial cells. Gastroenterol2006; 130: 398–411.
6.
ComabellaMFernandezMMartinRRivera-VallvéSBorrásEChivaC. Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis. Brain2010; 133: 1082–1093.
7.
ReckliesADWhiteCLingH. The chitinase 3-like protein human cartilage glycoprotein 39 (HC-gp39) stimulates proliferation of human connective-tissue cells and activates both extracellular signal-regulated kinase- and protein kinase B-mediated signalling pathways. Biochem J2002; 365: 119–126.
8.
NishikawaKCMillisAJ. gp38k (CHI3L1) is a novel adhesion and migration factor for vascular cells. Exp Cells Res2003; 287: 79–87.
9.
PoserCMPatyDWScheinbergLMcDonaldWIDavisFAEbersGC. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol1983; 13: 227–231.
10.
McDonaldWICompstonAEdanGGoodkinDHartungHPLublinFD. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol2001; 50: 121–127.
11.
WingerchukDMLennonVAPittockSJLucchinettiCFWeinshenkerBG. Revised diagnostic criteria for neuromyelitis optica. Neurology2006; 66: 1485–1489.
12.
CorrealeJRushCAmengualAGoicocheaMT. Mitoxantrone as rescue therapy in worsening relapsing-remitting MS patients receiving IFN-beta. J Neuroimmunol2005; 162: 173–183.
13.
AlterADuddyMHebertSBiernackiKPratAAntelJP. Determinants of human B cell migration across brain endothelial cells. J Immunol2003; 170: 4497–4505.
14.
BootRGRenkemaGHStrijlandAvan ZonneveldAJAertsJM. Cloning of cDNA encoding chitotriosidase, a human chitinase produced by macrophages. J Biol Chem1995; 270: 26252–26256.
15.
van EijkMvan RoomenCPRenkemaGHBussinkAPAndrewsLBlommaartEF. Characterization of human phagocyte-derived chitotriosidase, a component of innate immunity. Int Immunol2005; 17: 1505–1512.
16.
BaroneRDi GregorioFRomeoMASchiliroGPavoneL. Plasma chitotriosidase activity in patients with beta thalassemia. Blood Cell Mol Dis1999; 25: 1–8.
17.
HollakCEvan WeelySvan OersMHAertsJM. Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease. J Clin Invest1994; 93: 1288–1292.
18.
AertsJMHollakCBootRGroenerA. Biochemistry of glycosphingolipid storage disorders: implications for therapeutic intervention. Philos Trans R Soc Lon B Biol Sci2003; 385: 905–914.
19.
HornerRJZhuZCohnLLeeCGWhiteWIChenS. Differential expression of chitinases identify subsets of murine airway epithelial cells in allergic inflammation. Am J Physiol Lung Cell Mol Physiol2006; 291: L502–L511.
20.
HakalaBEWhiteCReckliesAD. Human cartilage gp-39, a major secretory product of articular chondrocytes and synovial cells is a mammalian member of chitinase protein family. J Biol Chem1993; 268: 25803–23810.
21.
JohansenJSMilmanNHansenMGarbarschCPricePAGraudalN. Increased serum YKL-40 in patients with pulmonary sarcoidosis –a potential marker of disease activity?Respir Med2005; 99: 396–402.
22.
LeeCG. Chitin, chitinases and chitinase-like proteins in allergic inflammation and tissue remodeling. Yonsei Med J2009; 50: 22–30.
23.
SotgiuSBaroneRArruGFoisMLPugliattiMSannaA. Intrathecal chitotriosidase and the outcome of multiple sclerosis. Mult Scler2006; 12: 551–557.
KronborgGØstergaardCWeisNObelSPedersenSSPricePA. The serum level of YKL-40 is elevated in patients with Streptococcus pneumoniae bacteremia and is associated to the outcome of the disease. Scand J Infect Dis2002; 34: 323–326.
26.
ØstergaardCJohansenJSBenfieldTPricePALundgrenJD. YKL-40 is elevated in cerebrospinal fluid from patients with purulent meningitis. Clin Diagn Lab Immunol2002; 9: 598–604.
27.
JensenBVJohansenJSPricePA. High levels of serum HER-2/neu and YKL-40 independently reflect aggressiveness of metastatic breast cancer. Clin Cancer Res2003; 9: 501–512.
28.
MitsuhashiAMatsuiHUsuiHNagaiYTateSUnnoY. Serum YKL-40 as a marker for cervical adenocarcinoma. Ann Oncol2009; 20: 71–77.
29.
VosKSteenbakkersPMiltenburgAMBosEvan den HeuvelMWvan HogezandRA. Raised human cartilage glycoprotein-39 plasma levels in patients with rheumatoid arthritis and other inflammatory conditions. Ann Rheum Dis2000; 59: 544–548.
30.
KoutroubakisIEPetinakiEDimouliosPVardasERoussomoustakakiMManiatisAN. Increased serum levels of YKL-40 in patients with inflammatory bowel disease. Int J Colorectal Dis2003; 18: 254–259.
31.
ChuppGLLeeCGJarjourNShimYMHolmCTHeS. A chitinase-like protein in the lung and circulation of patients with severe asthma. New Engl J Med2007; 357: 2016–2027.
32.
BierbaumSNickelRKochALauSDeichmannKAWahnU. Polymorphisms and haplotypes of acid mammalian chitinase are associated with bronchial asthma. Am J Respir Crit Care Med2005; 172: 1505–1509.
33.
OberCTanZSunYPossickJDPanLNicolaeR. Effect of variation in CHI3L1 on serum YKL-40 level, risk of asthma, and lung function. New Engl J Med2008; 358: 1682–1691.
34.
VindIJohansenJSPricePAMunkholmP. Serum YKL-40, a potential new marker of disease activity in patients with inflammatory bowel disease. Scand J Gastroenterol2003; 38: 599–605.
35.
JohansenJSJemsenHSPricePA. A new biochemical marker for joint injury. Analysis of YKL-40 in serum and synovial fluid. Br J Rheumatol1993; 32: 949–955.
36.
JohansenJSHvolrisJHansenMBackerVLorenzenIPricePA. Serum YKL-40 levels in healthy children and adults. Comparison with serum and synovial fluid levels of YKL-40 in patients with osteoarthritis or trauma of the knee joint. Br J Rheumatol1996; 35: 553–559.
37.
LucchinettiCFMandlerRNMcGavernDBruckWGleichGRansohoffRM. A role of humoral mechanisms in the pathogenesis of Devic’s neuromyelitis optica. Brain2002; 125: 1450–1461.
38.
CorrealeJFiolM. Activation of humoral immunity and eosinophils in neuromyelitis optica. Neurology2004; 63: 2363–2370.
39.
ZhengMCaiWMZhaoJKZhuSMLiuRH. Determination of serum levels of YKL-40 and hyaluronic acid in patients with hepatic fibrosis due to schistosomiasis japonica and appraisal of their clinical value. Acta Trop2005; 96: 148–152.
40.
KzhyshkowskaJGratchevAGoerdtS. Human chitinases and chitinase-like proteins as indicators for inflammation and cancer. Biomark Insights2007; 2: 128–146.
41.
SutherlandTEMaizelsRMAllenJE. Chitinase and chitinase-like proteins: potential therapeutic targets for the treatment of T-helper type 2 allergies. Clin Exp Allergy2009; 39: 943–955.
42.
ShuhuiLMokYKWongWSF. Role of mammalian chitinases in asthma. Int Arch Allergy Immunol2009; 149: 369–377.
